SYSTEMATIC REVIEW
Accepted on 19 May 2025
Efficacy and safety of PI3K inhibitors combined with fulvestrant for HR+/HER2-advanced breast cancer: a systematic review and metaanalysis
doi 10.3389/fonc.2025.1556978
- Frontiers in Oncology
- Breast Cancer
- Research Topics
- Liquid Biopsy and Circulating Tumor DNA Assays in the Management of Breast Cancer
Liquid Biopsy and Circulating Tumor DNA Assays in the Management of Breast Cancer
1,227
Total downloads
4,820
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.